Evidence map›Paper›PMID 32423949›Full record

ArticleAntimicrobial agents and chemotherapy2020

Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.

Inga Fröding, Badrul Hasan, Isak Sylvin, Maarten Coorens, Pontus Nauclér, Christian G Giske

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 24 citations in OpenAlex.

  1. Molecular characterization of extended-spectrum β-lactamases-producing Escherichia coli isolated from patients with bacteremia.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Article
  3. High clonal diversity, resistome, and virulome ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Inga FrödingDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden inga.froding@sll.se.
Badrul HasanDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Isak SylvinDepartment of Clinical Microbiology, Karolinska University Laboratory, Stockholm, Sweden.
Maarten CoorensDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Pontus NauclérDepartment of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Christian G GiskeDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive infections due to extended-spectrum-β-lactamase- and pAmpC-producing

Indexed as

Escherichia coli InfectionsSepsisShock, SepticAnti-Bacterial Agentsbeta-LactamasesClone CellsEscherichia coliHumansMalePlasmidsVirulenceAnti-Bacterial Agentsbeta-LactamasesbacteremiaESBLEscherichia colimedical outcomesmortalityvirulence factorsWGS

Identifiers

PMID32423949
PMCPMC7526827
OpenAlexW3024078536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.